Toxicity of Phase I Radiation Oncology Trials: Worldwide Experience

doi 10.29046/tbj.003.1.030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Thomas Jefferson University

Related search

A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies

Oncologist
Cancer ResearchMedicineOncology
2020English

Communication About the Risks and Benefits of Phase I Pediatric Oncology Trials

Contemporary Clinical Trials
MedicinePharmacology
2015English

Relationship Between Response and Dose in Published, Contemporary Phase I Oncology Trials

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2020English

Perceptions and Referral Trends Into Phase I Oncology Trials: Results of a Clinical Survey

Journal of Oncology
Oncology
2011English

Early Experience and Quality of Life Comparison in Prostate Cancer Brachytherapy Versus Phase I-Ii Stereotactic Body Radiation Therapy Trials

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

A Novel Toxicity Scoring System Treating Toxicity Response as a Quasi-Continuous Variable in Phase I Clinical Trials

Contemporary Clinical Trials
MedicinePharmacology
2010English

Escalation With Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials

PLoS ONE
Multidisciplinary
2014English

Predictors of Success of Phase II Pediatric Oncology Clinical Trials

Oncologist
Cancer ResearchMedicineOncology
2019English

Critical Appraisal of Clinical Trials in Oncology — Part I

Oncology in Clinical Practice
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy